Samueli Henry
Director at Broadcom · 10% owner at Sensei Biotherapeutics
Samueli Henry — Director at Broadcom · 10% owner at Sensei Biotherapeutics — has filed 40 SEC Form 4s covering 163 transactions at 2 companies since Mar 2018, most recently on Sep 23, 2026. Open-market activity: 1 purchase worth $36.8M and 88 sales worth $1.25B. The latest filing reports 35,811,088 AVGO shares of Broadcom, worth $12.7B at the latest close, one of 2 reported positions.
Bought
$36.8M
1 open-market
Sold
$1.2B
88 open-market
Companies
2
40 filings
Value of reported holdings
Reported positions
AVGOpart indirect
35,811,088 shares · filed Sep 23, 2026 · Broadcom
$12.72B
100%
SNSE
4,425,998 shares · filed Feb 8, 2021 · Sensei Biotherapeutics
not priced
$12.72B across 2 companies where they file as an insider.